Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin

Nav

General Info

Geography

Belgium (BEL)

Czechia (CZE)

France (FRA)

Germany (DEU)

Greece (GRC)

Hungary (HUN)

Ireland (IRL)

Israel (ISR)

Italy (ITA)

Poland (POL)

Portugal (PRT)

Russian Federation (RUS)

Slovenia (SVN)

Spain (ESP)

Sweden (SWE)

Türkiye (TUR)

Ukraine (UKR)

United Kingdom (GBR)

View all

Coverage type

Country

Time period covered

01/2011 - 12/2013

Data type

Scientific literature

Keywords

Drug resistance

Citation

Authors

Mendes RE, Flamm RK, Farrell DJ, Sader HS, Jones RN

Journal

J Chemother

Volume

Issue

Pages

83-8

Publication year

2016

Suggested citation

Mendes RE, Flamm RK, Farrell DJ, Sader HS, Jones RN. Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. J Chemother. 2016; 28(2): 83-8.

DOI

10.1179/1973947815Y.0000000050

PMID

26058844

GHDx Entry last modified on: May 23, 2024

Header sites

Search form

Main menu

Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin

Nav